Cargando…
Capmatinib suppresses LPS-induced interaction between HUVECs and THP-1 monocytes through suppression of inflammatory responses
BACKGROUND: Capmatinib (CAP) is a drug that has been used to treat non-small cell lung cancer (NSCLC) in adults. Presently, its novel effects on skeletal muscle insulin signaling, inflammation, and lipogenesis in adipocytes have been uncovered with a perspective of drug repositioning. However, the i...
Autores principales: | Park, Hyung Sub, Abd El-Aty, A.M., Jeong, Ji Hoon, Lee, Taeseung, Jung, Tae Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chang Gung University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267969/ https://www.ncbi.nlm.nih.gov/pubmed/35483573 http://dx.doi.org/10.1016/j.bj.2022.04.005 |
Ejemplares similares
-
Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes
por: Bertuccio, Maria Paola, et al.
Publicado: (2023) -
Lactococcus lactis-fermented spinach juice suppresses LPS-induced expression of adhesion molecules and inflammatory cytokines through the NF-κB pathway in HUVECs
por: Lee, Sang-Hee, et al.
Publicado: (2022) -
MKP-3 suppresses LPS-induced inflammatory responses in HUVECs via inhibition of p38 MAPK/NF-κB pathway
por: Unenkhuu, Banzragchgarav, et al.
Publicado: (2021) -
β-aminoisobutyric acid attenuates LPS-induced inflammation and insulin resistance in adipocytes through AMPK-mediated pathway
por: Jung, Tae Woo, et al.
Publicado: (2018) -
Ginsenoside Rb3 ameliorates podocyte injury under hyperlipidemic conditions via PPARδ- or SIRT6-mediated suppression of inflammation and oxidative stress
por: Oh, Heeseung, et al.
Publicado: (2023)